Sale of Common Stock (Details) (USD $)	1 Months Ended		3 Months Ended		9 Months Ended			1 Months Ended	3 Months Ended		1 Months Ended	3 Months Ended		0 Months Ended			0 Months Ended
	Sep. 30, 2013	Feb. 28, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Sep. 30, 2013 September 2013 Warrants	Sep. 30, 2013 September 2013 Warrants	Sep. 18, 2013 September 2013 Warrants	Sep. 30, 2013 September 2013 SPA Option	Sep. 30, 2013 September 2013 SPA Option	Sep. 18, 2013 September 2013 SPA Option	Sep. 18, 2013 September 2013 SPA	Sep. 18, 2013 September 2013 SPA September 2013 Investor Warrants	Sep. 18, 2013 September 2013 SPA September 2013 Placement Agent Warrants	Sep. 18, 2013 September 2013 SPA September 2013 Warrants	Sep. 18, 2013 September 2013 SPA September 2013 SPA Option High end of range	Sep. 18, 2013 September 2013 Right to Shares Agreement item	Sep. 30, 2013 September 2013 Right to Shares Agreement
Sale of Common Stock
Shares of common stock sold	125,000,000		125,000,000		125,000,000		32,434,000							29,166,668
Common stock issuable under warrants															29,166,668	1,485,333
Gross proceeds from sale of common stock	$ 1,750,000	$ 4,040,000													$ 1,750,000
Net proceeds from sale of common stock															1,575,329
Term to hold share purchase														24 months
Number of investors entered into agreement																			1
Common stock, shares unissued	37,538,000		37,538,000		37,538,000														16,666,667
Rights to purchase common stock (in shares)																			16,666,667
Additional consideration paid upon the issuance of the shares																			0
Period for obligation to deliver shares																			3 days
Common stock, shares reserved but unissued	37,538,000		37,538,000		37,538,000															16,666,667
Portion of shares of common stock and warrants available for same per share purchase price (as a percent)																		0.5
Number of common stocks purchased under the option											0
Warrants
Number of warrants exercised								0
Beginning balance (in shares)										30,625,001			14,583,334
Ending balance (in shares)								30,625,001	30,625,001	30,625,001	14,583,334	14,583,334	14,583,334
Term of warrants																	5 years
Number of shares exercisable under warrants issued																	30,625,001
Exercise price of warrants (in dollars per share)								$ 0.08	$ 0.08	$ 0.08	$ 0.06	$ 0.06	$ 0.06				$ 0.08
Period for presenting effective registration statement for avoiding cashless exercise of warrants																	180 days
Limitation of beneficial ownership of common stock for exercise of warrants (as a percent)																	4.99%
Discretionary increase in limitation of beneficial ownership of common stock for exercise of warrants (as a percent)																	9.99%
Notice period for discretionary increase in limitation of beneficial ownership of common stock for exercise of warrants																	61 days
Grant date fair value								1,807,000	1,807,000		1,166,000	1,166,000
Fair value of derivative liability								1,574,000	1,574,000		875,000	875,000
Impact to other income (expense)			$ 1,078,000	$ (1,117,000)	$ 3,192,000	$ (3,517,000)			$ 233,000			$ 291,000